Letters sent to healthcare professionals in August 2017

Letters were sent about INOmax (nitric oxide) cylinders and triptorelin (Decapeptyl).

• From: Medicines and Healthcare products Regulatory Agency
• Published: 26 September 2017
• Last updated: 26 September 2017 — See all updates

• Therapeutic area: Anaesthesia and intensive care, Cancer, Endocrinology, diabetology and metabolism, Paediatrics and neonatology and Respiratory disease and allergy

In August 2017, the following letters were sent to relevant healthcare professionals to inform them of updated safety information:

• INOmax (nitric oxide) cylinders: gas delivery might stop in the month of expiry when used with the Device INOmax DSIR

• Decapeptyl SR (Triptorelin) 11.25 mg: change in salt

Article citation: Drug Safety Update volume 11 issue 2, September 2017: 3.

Published 26 September 2017
Last updated 26 September 2017 + show all updates

1. 26 September 2017

   Edited order

2. 26 September 2017

   Correct issue

3. 26 September 2017

   First published.